help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Musey, V. C.
Right arrow Articles by Preedy, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Musey, V. C.
Right arrow Articles by Preedy, J. R.

Journal of Clinical Endocrinology & Metabolism, Vol 64, 111-118, Copyright © 1987 by Endocrine Society


ARTICLES

Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens

VC Musey, DC Collins, DR Brogan, VR Santos, PI Musey, D Martino-Saltzman and JR Preedy

An early (but not a late) first pregnancy is known to be protective for breast cancer. This effect might be mediated through a long term change in the hormonal environment caused by the early first pregnancy. To investigate the possibility of such a change we carried out a prospective longitudinal study of serum and urinary estrogens and serum androgens in four groups of women, namely early (age, 18-23 yr) first pregnancy (n = 15), early control (n = 20), late (age, 29-40 yr) first pregnancy (n = 9), and late control (n = 20). The pregnancy groups were studied before (initial visit) and 7-19 months after a first pregnancy (return visit). The control groups were similarly studied, but without an intervening pregnancy. The following were measured: serum estrone (E1), 17 beta-estradiol (E2), estriol (E3), and E1 sulfate; urinary total E1, E2, E3, and glucosiduronates of these three estrogens; and serum testosterone, dehydroepiandrosterone sulfate (DHAS), and dehydroepiandrosterone (DHA). There was no significant change between the initial and return visits in serum E1, E2, E1 sulfate, or any of the urinary estrogens in either pregnancy group or in the corresponding control groups. There was, however, a significant increase in serum E3 between initial and return visits for both pregnancy groups compared with the control values. There was no significant change in serum testosterone. There was a marked significant decrease in both serum DHAS and DHA between initial and return visits in both pregnancy groups compared with the corresponding control group values. There was also a significant increase in the serum E3 to DHA ratio in both pregnancy groups. A cross-sectional study (measuring serum DHAS and DHA only) was then carried out in a series of parous and nulliparous women. The serum DHAS and DHA levels were markedly and significantly lower in parous than in nulliparous women, as expected. There was no significant relationship between serum DHAS or DHA levels and months elapsed (up to 150) since last delivery, indicating that the changes last at least for this period of time. There was no significant relationship between serum DHAS or DHA levels and parity (one to three previous pregnancies), indicating that the changes occur only after a first pregnancy.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. A. Arslan, A. Zeleniuch-Jacquotte, A. Lukanova, Y. Afanasyeva, J. Katz, M. Levitz, G. Del Priore, and P. Toniolo
Effects of Parity on Pregnancy Hormonal Profiles Across Ethnic Groups with a Diverse Incidence of Breast Cancer.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2123 - 2130.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Faupel-Badger, S. A. Prindiville, D. Venzon, B. K. Vonderhaar, J. A. Zujewski, and J. Eng-Wong
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1153 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. A. Missmer, S. E. Hankinson, D. Spiegelman, R. L. Barbieri, S. Malspeis, W. C. Willett, and D. J. Hunter
Reproductive History and Endometriosis Among Premenopausal Women
Obstet. Gynecol., November 1, 2004; 104(5): 965 - 974.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. P. Gunderson, C. E. Lewis, M. A. Murtaugh, C. P. Quesenberry, D. Smith West, and S. Sidney
Long-term Plasma Lipid Changes Associated with a First Birth: The Coronary Artery Risk Development in Young Adults Study
Am. J. Epidemiol., June 1, 2004; 159(11): 1028 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. A. Wise, J. R. Palmer, B. L. Harlow, D. Spiegelman, E. A. Stewart, L. L. Adams-Campbell, and L. Rosenberg
Reproductive Factors, Hormonal Contraception, and Risk of Uterine Leiomyomata in African-American Women: A Prospective Study
Am. J. Epidemiol., January 15, 2004; 159(2): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Cotterchio, N. Kreiger, B. Theis, M. Sloan, and S. Bahl
Hormonal Factors and the Risk of Breast Cancer According to Estrogen- and Progesterone-Receptor Subgroup
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1053 - 1060.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Lambe and A. Ekbom
Cancers coinciding with childbearing: delayed diagnosis during pregnancy?
BMJ, December 16, 1995; 311(7020): 1607 - 1608.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society